The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial - Bureau, C; Thabut, D; Jezequel, C (Ann Intern Med, 2021)